Barrett & Company disclosed a new $790,000 position in Taiwan Semiconductor Manufacturing Company in its latest 13F filing, a modest but directional move that mirrors broader institutional reweightings across the semiconductor supply chain. The investment manager, which oversees approximately $140 million in reportable assets, entered the position during Q4 2024 while global foundry utilization rates stabilized above 85% and hyperscaler capex commitments for 2025 hardened.

The timing aligns with a six-week period in late November and December when TSM's American depositary receipts traded in a $172-$198 range, offering entry points below the stock's January highs. Barrett's allocation represents roughly 0.56% of its disclosed equity portfolio, a weighting consistent with sector bets rather than core holdings. The firm joins a cohort of mid-tier managers who added semiconductor exposure after TSM's October earnings call clarified 3-nanometer yield improvements and reaffirmed $38-$42 billion in 2025 capital expenditures.

This matters because small and mid-sized investment managers often trail institutional whales by one to two quarters, and their 13F disclosures provide a lagging but reliable read on where regional allocators see late-cycle value. Barrett's entry follows $2.1 billion in net institutional inflows into TSM during Q3 2024, according to aggregated 13F data, and precedes the chipmaker's Arizona fab ramp, which reaches volume production in H2 2025. The firm's move also coincides with a 160-basis-point contraction in TSM's forward price-to-earnings multiple since August, creating a window for managers who missed the 2023 rally.

The broader context includes Samsung's ongoing 3-nanometer yield struggles and Intel Foundry's $3.5 billion in Q4 operating losses, both of which tighten the market for leading-edge logic and amplify TSM's pricing leverage. Barrett's portfolio construction skews toward cash-generative industrials and select technology names with visible earnings paths, making the TSM position a vote for margin expansion rather than speculative upside. The firm has not historically rotated quickly, which suggests the stake may expand if TSM's March quarter guidance exceeds the $25-$26 billion revenue band analysts currently model.

Allocators should track TSM's April 17 earnings release for commentary on 2-nanometer customer commitments and any incremental fab investment tied to U.S. CHIPS Act disbursements, which remain $6.6 billion in approved but not-yet-deployed funding. Barrett's 13F also shows a $320,000 reduction in Broadcom and a $480,000 trim in Nvidia, implying a rotation from high-beta semiconductor names into the foundry layer. The firm's next disclosure window opens May 15, which will reveal whether this position was a one-time entry or the start of a multi-quarter build.

TSM's Arizona facility begins pilot production of 4-nanometer wafers in Q2 2025, with Apple and AMD as anchor customers. Barrett's stake is too small to move markets, but it reflects a class of allocator that waits for re-rating opportunities after momentum fades and operational improvements clarify.